Cofco Biotechnology (000930.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
According to the Zhitong Finance APP, Cofco Biotechnology (000930.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 15.124 billion yuan, a year-on-year increase of 2.74%. The net income attributable to shareholders of the listed company was 9.605 million yuan, a year-on-year increase of 102.89%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 40.1558 million yuan.
